Value of a molecular screening program to support clinical trial enrollment in Asian cancer patients: The Integrated Molecular Analysis of Cancer (IMAC) Study

• Main Authors: Heong V., Syn N.L., Lee X.W., Sapari N.S., Koh X.Q., Adam Isa Z.F., Sy Lim J., Lim D., Pang B., Thian Y.L., Ng L.K., Wong A.L., Soo R.A., Yong W.P., Chee C.E., Lee S.-C., Goh B.-C., Soong R., Tan D.S.P.
• Other Authors: CANCER SCIENCE INSTITUTE OF SINGAPORE
• Format: Article
• Published: Wiley-Liss Inc. 2020
• Subjects: biomarker-driven clinical trials; next-generation sequencing; precision medicine; precision oncology; targeted therapy
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/175943
• Institution: National University of Singapore

10.1002/ijc.31091